25 studies found for: " May 06, 2009":" June 05, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
Anal Cancer Screening Study
CyberSenga: Internet-based HIV Prevention in Uganda
Collecting and Storing Blood Samples From Patients With Cancer
† Indicates status has not been verified in more than two years